Kathryn J. Wood

Q: What Schools Are Affiliated With Kathryn J. Wood

Kathryn J. Wood is affiliated with the following schools: Teikyo University, University of Oxford

Kathryn J. Wood's AcademicInfluence.com Rankings

Kathryn J. Wood

Philosophy

#5267

World Rank

#8024

Historical Rank

Logic

#2574

World Rank

#3586

Historical Rank

philosophy Degrees

Kathryn J. Wood

Biology

#7038

World Rank

#9886

Historical Rank

Immunology

#373

World Rank

#387

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Kathryn J. Wood's Degrees

PhD Immunology University of Oxford
Doctorate Medicine University of Oxford

Why Is Kathryn J. Wood Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kathryn J. Wood's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (1083)
CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1 (2002) (810)
Regulatory lymphocytes: Regulatory T cells in transplantation tolerance (2003) (769)
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. (2010) (497)
Regulatory immune cells in transplantation (2012) (398)
Indirect presentation of MHC antigens in transplantation. (1994) (361)
Mechanisms of rejection: current perspectives. (2012) (323)
IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo (2005) (318)
Mesenchymal stromal cells: facilitators of successful transplantation? (2010) (302)
In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells (2010) (297)
Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9 (2009) (280)
The Th1/Th2 paradigm and the allograft response. (1996) (270)
Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation (2004) (270)
IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival (2011) (237)
Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes (1988) (226)
Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant Recipients (2011) (222)
Alloantigen-Induced CD25+CD4+ Regulatory T Cells Can Develop In Vivo from CD25−CD4+ Precursors in a Thymus-Independent Process 1 (2004) (218)
Chimerism and transplantation tolerance: cause and effect. (1996) (217)
Production and Implantation of Renal Extracellular Matrix Scaffolds From Porcine Kidneys as a Platform for Renal Bioengineering Investigations (2012) (211)
Allograft rejection mediated by memory T cells is resistant to regulation (2007) (205)
Ex Vivo–Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse Model (2010) (199)
Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy1 (2002) (198)
Interferon γ: a crucial role in the function of induced regulatory T cells in vivo (2006) (195)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials (2020) (194)
Regulatory T Cells in Transplantation (2011) (189)
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. (2007) (175)
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model (2013) (170)
Regenerative medicine and organ transplantation: past, present, and future. (2011) (162)
Immune responses to adenovirus vectors in the nervous system (1996) (157)
Regenerative medicine as applied to solid organ transplantation: current status and future challenges (2011) (153)
INDUCTION OF TRANSPLANTATION TOLERANCE IN ADULTS USING DONOR ANTIGEN AND ANTI‐CD4 MONOCLONAL ANTIBODY (1992) (151)
Transplantation tolerance induced by antigen pretreatment and depleting anti‐CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response (1995) (151)
Operational tolerance after liver transplantation. (2009) (150)
Regulatory T cells in transplantation. (2002) (148)
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation (2017) (143)
CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. (2005) (136)
B Cell Repopulation After Alemtuzumab Induction—Transient Increase in Transitional B Cells and Long-Term Dominance of Naïve B Cells (2012) (124)
Homeostatic Repopulation by CD28−CD8+ T Cells in Alemtuzumab‐Depleted Kidney Transplant Recipients Treated With Reduced Immunosuppression (2008) (124)
Clinical Operational Tolerance After Renal Transplantation: Current Status and Future Challenges (2010) (122)
Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. (2007) (119)
The Presence of Foxp3 Expressing T Cells Within Grafts of Tolerant Human Liver Transplant Recipients (2008) (117)
Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. (1996) (115)
Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats (1987) (115)
The Impact of Memory T Cells on Rejection and the Induction of Tolerance (2006) (113)
Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. (2006) (109)
Exogenous IFN-γ ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells (2008) (105)
Interferon-&ggr; Conditioning Ex Vivo Generates CD25+CD62L+Foxp3+ Regulatory T Cells That Prevent Allograft Rejection: Potential Avenues for Cellular Therapy (2008) (104)
Immune responses to adenoviral vectors during gene transfer in the brain. (1997) (103)
Moving to tolerance: clinical application of T regulatory cells. (2011) (103)
The impact of Th17 cells on transplant rejection and the induction of tolerance (2010) (101)
Role of T cells in graft rejection and transplantation tolerance (2010) (99)
Regenerative medicine as applied to general surgery. (2012) (97)
The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. (1987) (97)
Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect (2003) (96)
Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. (1996) (94)
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation (2009) (94)
Evidence for immune regulation in the induction of transplantation tolerance: a conditional but limited role for IL-4. (1999) (90)
Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack (2008) (90)
Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies (1996) (90)
Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. (1995) (89)
Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo (2012) (88)
Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. (1997) (88)
Cross‐Validation of IFN‐γ Elispot Assay for Measuring Alloreactive Memory/Effector T Cell Responses in Renal Transplant Recipients (2013) (86)
Mesenchymal stromal cells in transplantation rejection and tolerance. (2013) (85)
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. (1998) (84)
THE ASSESSMENT OF TRANSPLANTATION TOLERANCE INDUCED BY ANTI‐CD4 MONOCLONAL ANTIBODY IN THE MURINE MODEL1 (1993) (84)
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. (2010) (84)
Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells (2010) (83)
The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation. (2005) (83)
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials (2018) (83)
Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning (2014) (82)
Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model (2013) (81)
CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. (2000) (80)
EVIDENCE THAT LONG‐TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI‐CD4 MONOCLONAL ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T CELLS (1992) (80)
Costimulation blockade: current perspectives and implications for therapy. (2013) (77)
Regulatory T cells in transplantation: transferring mouse studies to the clinic. (2009) (76)
Recipient Memory-Like Lymphocytes Remain Unresponsive to Graft Antigens After CAMPATH-1H Induction with Reduced Maintenance Immunosuppression (2006) (75)
Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. (2011) (75)
Transfusion induces blood donor-specific suppressor cells. (1989) (74)
Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. (1985) (74)
Th17: Contributors to Allograft Rejection and a Barrier to the Induction of Transplantation Tolerance? (2011) (71)
GITR Ligation Blocks Allograft Protection by Induced CD25+CD4+ Regulatory T Cells without Enhancing Effector T‐Cell Function (2007) (71)
The Generation of CD25+CD4+ Regulatory T Cells That Prevent Allograft Rejection Does Not Compromise Immunity to a Viral Pathogen 1 (2005) (71)
Regulatory T cells: first steps of clinical application in solid organ transplantation (2016) (68)
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement (2016) (67)
Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection (2011) (67)
Transplantation tolerance: lessons from experimental rodent models (2007) (64)
Location and Time-Dependent Control of Rejection by Regulatory T Cells Culminates in a Failure to Generate Memory T Cells1 (2008) (64)
Regulatory T cells for tolerance. (2017) (64)
Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. (1996) (64)
Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? (2007) (63)
Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells (2010) (61)
In Vivo Quantification of Vcam-1 Expression in Renal Ischemia Reperfusion Injury Using Non-Invasive Magnetic Resonance Molecular Imaging (2010) (60)
Current landscape for T-cell targeting in autoimmunity and transplantation. (2011) (59)
Immunogenicity of embryonic stem cell-derived progenitors after transplantation (2011) (59)
Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model (2012) (58)
Induction of transplantation tolerance-the potential of regulatory T cells. (2005) (58)
Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. (2005) (57)
B cells with immune-regulating function in transplantation (2014) (57)
Intravenous Immunoglobulins Promote Skin Allograft Acceptance by Triggering Functional Activation of CD4+Foxp3+ T cells (2010) (56)
Single cell tracking of gadolinium labeled CD4+ T cells by laser ablation inductively coupled plasma mass spectrometry. (2013) (54)
Predictors of Cancer Risk in the Long-Term Solid-Organ Transplant Recipient (2014) (54)
Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. A protocol with significant clinical potential. (1994) (54)
The Specific Monocarboxylate Transporter (MCT1) Inhibitor, AR-C117977, a Novel Immunosuppressant, Prolongs Allograft Survival in the Mouse (2007) (54)
An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients (2007) (54)
Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft. (1996) (53)
ISLET ALLOGRAFT REJECTION CAN BE MEDIATED BY CD4+, ALLOANTIGEN EXPERIENCED, DIRECT PATHWAY T CELLS OF TH1 AND TH2 CYTOKINE PHENOTYPE1 (2000) (52)
Passenger leukocytes and microchimerism: what role in tolerance induction? (2003) (52)
Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti‐HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients (2018) (51)
Assessment of primarily vascularized cardiac allografts in mice. (1986) (51)
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients (2020) (51)
The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells (2018) (49)
CD4+ regulatory T cells in solid organ transplantation (2010) (49)
Effector and Memory CD8+ T Cells Can Be Generated in Response to Alloantigen Independently of CD4+ T Cell Help1 (2006) (48)
Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques. (2005) (48)
Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming (1999) (47)
Understanding FOXP3: progress towards achieving transplantation tolerance. (2007) (47)
Variation in MHC Expression Between Undifferentiated Mouse ES Cells and ES Cell-derived Insulin-producing Cell Clusters (2009) (47)
CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression (2016) (47)
Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade. (1994) (46)
Exhaustive Differentiation of Alloreactive CD8+ T Cells: Critical for Determination of Graft Acceptance or Rejection (2008) (45)
Humoral immune responses to adenovirus vectors in the brain (2000) (44)
Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation. (2010) (44)
Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. (2002) (42)
Deletion of alloantigen‐reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration (1997) (42)
T regulatory cells and the control of alloimmunity: from characterisation to clinical application (2010) (41)
Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions? (2013) (41)
Regulatory cells in transplantation. (2003) (40)
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization (2018) (39)
Understanding Stem Cell Immunogenicity in Therapeutic Applications. (2016) (39)
Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation1 (2003) (39)
A Diametric Role for OX40 in the Response of Effector/Memory CD4+ T Cells and Regulatory T Cells to Alloantigen (2013) (38)
Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts1 (2002) (37)
BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION. (2012) (37)
Transplantomics and Biomarkers in Organ Transplantation: A Report From the First International Conference (2011) (37)
How regenerative medicine may contribute to the achievement of an immunosuppression-free state. (2011) (37)
Th17 Cells in Alemtuzumab-Treated Patients: The Effect of Long-Term Maintenance Immunosuppressive Therapy (2011) (36)
The Generation of Donor-Specific CD4+CD25++CD45RA+ Naive Regulatory T Cells in Operationally Tolerant Patients After Pediatric Living-Donor Liver Transplantation (2010) (36)
Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. (2000) (35)
Regulation of Transplant Arteriosclerosis by CD25+CD4+ T Cells Generated to Alloantigen In Vivo (2007) (35)
Fas ligand-transfected myoblasts and islet cell transplantation. (2000) (34)
Alloantigen-induced specific immunological unresponsiveness. (2001) (34)
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes) (2020) (34)
T-cell activation, proliferation, and memory after cardiac transplantation in vivo. (1999) (33)
The where and when of T cell regulation in transplantation. (2013) (33)
Mesenchymal stromal cells; role in tissue repair, drug discovery and immune modulation. (2013) (33)
The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft. (1992) (33)
Tolerance: One Transplant for Life (2014) (33)
Interferon Gamma: Friend or Foe? (2007) (33)
Translating tolerogenic therapies to the clinic – where do we stand? (2012) (33)
Analysis of the peripheral T‐cell repertoire in kidney transplant patients (2010) (32)
Alpha-1,2-Mannosidase and Hence N-Glycosylation Are Required for Regulatory T Cell Migration and Allograft Tolerance in Mice (2010) (32)
Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. (2013) (32)
A Shift towards Pro-Inflammatory CD16+ Monocyte Subsets with Preserved Cytokine Production Potential after Kidney Transplantation (2013) (31)
IFN-γ Triggered STAT1-PKB/AKT Signalling Pathway Influences the Function of Alloantigen Reactive Regulatory T Cells (2010) (31)
Examination of serum miRNA levels in kidney transplant recipients with acute rejection. (2014) (31)
CD25+CD4+ Regulatory T Cells Develop in Mice Not Only During Spontaneous Acceptance of Liver Allografts but Also After Acute Allograft Rejection (2006) (31)
CD4: A potential target molecule for immunosuppressive therapy and tolerance induction (1991) (31)
Anti-CD4-mediated selection of Treg in vitro – in vitro suppression does not predict in vivo capacity to prevent graft rejection (2008) (30)
Donor reactive regulatory T cells (2009) (30)
Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses. (2017) (29)
Natural killer T cells: a bridge to tolerance or a pathway to rejection? (2007) (29)
CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients. (2016) (28)
Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplants. (1992) (28)
Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection. (2000) (28)
Regulatory T cells: hypes and limitations. (2008) (28)
Anti-OX40 Prevents Effector T-Cell Accumulation and CD8+ T-Cell Mediated Skin Allograft Rejection (2010) (28)
Characteristics of the Early Immune Response Following Transplantation of Mouse ES Cell Derived Insulin-Producing Cell Clusters (2010) (28)
Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell Replacement. (2016) (28)
LACK OF CORRELATION BETWEEN THE INDUCTION OF DONOR CLASS I AND CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS AND GRAFT REJECTION (1988) (27)
Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype (2012) (27)
NONDEPLETING ANTI-CD4 MONOCLONAL ANTIBODY ENHANCES THE ABILITY OF ORAL ALLOANTIGEN DELIVERY TO INDUCE INDEFINITE SURVIVAL OF CARDIAC ALLOGRAFTS: ORAL TOLERANCE TO ALLOANTIGEN1 (2000) (27)
Inhibition of Chronic Rejection and Development of Tolerogenic T Cells after ICOS-ICOSL and CD40-CD40L Co-stimulation Blockade (2005) (27)
In Vivo Models of Inflammation (2003) (26)
Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo. (1998) (26)
Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion. (1988) (26)
IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS (2011) (26)
MEDIATION OF THE INDUCTION OF IMMUNOLOGIC UNRESPONSIVENESS FOLLOWING ANTIGEN PRETREATMENT BY A CD4 (W3/25+) T CELL APPEARING TRANSIENTLY IN THE SPLENIC COMPARTMENT AND SUBSEQUENTLY IN THE TDL (1989) (25)
CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis. (2010) (25)
Retroviral gene transfer of a donor class I MHC gene to recipient bone marrow cells induces tolerance to alloantigens in vivo. (1997) (24)
The Acquired Immune System Response to Biomaterials, Including Both Naturally Occurring and Synthetic Biomaterials (2015) (24)
Regulatory T cells can prevent memory CD8+ T-cell-mediated rejection following polymorphonuclear cell depletion (2010) (24)
INTRAGRAFT INTERLEUKIN-4 mRNA EXPRESSION AFTER SHORT-TERM CD154 BLOCKADE MAY TRIGGER DELAYED DEVELOPMENT OF TRANSPLANT ARTERIOSCLEROSIS IN THE ABSENCE OF CD8+ T CELLS1 (2000) (24)
MEDIATION OF ANTIGEN‐INDUCED SUPPRESSION OF RENAL ALLOGRAFT REJECTION BY A CD4 (W3/25+) T CELL (1989) (23)
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells (2020) (23)
HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function or outcome of renal transplants. (1989) (23)
PRODUCTION OF INDEFINITE RENAL ALLOGRAFT SURVIVAL IN THE RAT BY PRETREATMENT WITH VIABLE AND NONVIABLE HEPATOCYTES OR LIVER MEMBRANE EXTRACTS1 (1988) (23)
Dependency of Direct Pathway CD4+ T Cells on CD40-CD154 Costimulation Is Determined by Nature and Microenvironment of Primary Contact with Alloantigen1 (2004) (23)
Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study (2016) (22)
The Discovery of Immunological Tolerance: Now More Than Just a Laboratory Solution (2009) (22)
Transplantation tolerance with monoclonal antibodies. (1990) (22)
Regulatory T cells: potential in organ transplantation.1 (2004) (22)
Generation of highly effective and stable murine alloreactive Treg cells by combined anti‐CD4 mAb, TGF‐β, and RA treatment (2013) (22)
Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia (2010) (21)
Recombinant interleukin-2 (IL-2) can reverse the blood transfusion effect. (1989) (21)
New concepts in tolerance. (1996) (21)
The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions. (2000) (21)
Indirect allorecognition is involved in both acute and chronic allograft rejection. (1999) (21)
Regulatory T cell enrichment by IFN-γ conditioning. (2011) (20)
Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01 (2019) (20)
Pretransplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy. (2011) (20)
Intercellular cell adhesion molecule‐1 and selectin ligands in acute cardiac allograft rejection: a study on gene‐deficient mouse models (2002) (20)
Multiple Unit Pooled Umbilical Cord Blood is a Viable Source of Therapeutic Regulatory T Cells (2013) (20)
Ischemia-Reperfusion Injury Accelerates Human Antibody-Mediated Transplant Vasculopathy (2013) (19)
Effect of one-HLA-haplotype-matched and HLA-mismatched blood transfusions on recipient T lymphocyte allorepertoires. (1997) (19)
Platelet-endothelial cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis1 (2002) (19)
Regulatory T cells as modulators of chronic allograft dysfunction. (2011) (19)
Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy. (1987) (19)
Genetic aspects of the blood transfusion effect. (1988) (18)
Mechanisms of tolerance induction after intrathymic islet injection: determination of the fate of alloreactive thymocytes. (1999) (18)
Demethylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Transplant Recipients (2014) (18)
Resting B cells as tolerogens in vivo but only for minor histocompatibility antigens: evidence for activation of resting B cells in vivo. (1997) (18)
The induction of transplantation tolerance by intrathymic (i.t.) delivery of alloantigen: a critical relationship between i.t. deletion, thymic export of new T cells and the timing of transplantation. (1998) (18)
The Fourth International Workshop on Clinical Transplant Tolerance (2020) (18)
Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway1 (2002) (18)
Dependency of the Trans Vivo Delayed Type Hypersensitivity Response on the Action of Regulatory T Cells: Implications for Monitoring Transplant Tolerance (2006) (17)
Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness. (1995) (17)
Immunoregulatory Function of IL-27 and TGF-&bgr;1 in Cardiac Allograft Transplantation (2012) (17)
The role of the graft in establishing tolerance. (2002) (17)
Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and nonrejecting heart allografts. (2000) (17)
INABILITY OF DENDRITIC CELLS TO PREVENT THE BLOOD TRANSFUSION EFFECT IN A MOUSE CARDIAC ALLOGRAFT MODEL (1987) (17)
Successful secondary heterotopic cardiac transplantation in the mouse. (1992) (17)
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial (2021) (17)
Intrathymic administration of B cells induces prolonged survival of fully allogeneic cardiac grafts without prolonged deletion of donor-specific thymocytes. (1998) (16)
Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data. (2001) (16)
Gene therapy: potential applications in clinical transplantation (1999) (16)
Gene therapy and allotransplantation. (1997) (16)
Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts. (1995) (16)
TNFR2: The new Treg switch? (2017) (15)
The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation (2014) (15)
Pretreatment with lymphocyte subpopulations and renal allograft survival in the rat. (1987) (15)
Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS). (2011) (15)
Abrogation of the immunosuppressive effect of donor spleen cells on renal allografts in the rat by irradiation or heat treatment. (1986) (15)
Immune Tolerance and Rejection in Organ Transplantation. (2019) (15)
Semi‐allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness (1996) (15)
Immunoregulation by CD4 T cells in the induction of specific immunological unresponsiveness to alloantigens in vivo: evidence for a reduction in the frequency of alloantigen-specific cytotoxic T cells in vitro. (1998) (14)
The induction of tolerance to alloantigens using MHC class I molecules. (1993) (14)
Induction of tolerance to cardiac allografts. (1996) (14)
Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. (1993) (14)
Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour (1993) (14)
Spleen Plays an Important Role in Maintaining Tolerance After Removal of the Vascularized Heart Graft (2007) (13)
Minimal but essential doses of immunosuppression: a more realistic approach to improve long-term outcomes for pediatric living-donor liver transplantation. (2011) (13)
Inflammatory Ly-6Chi monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients (2012) (13)
Permanent survival of organ transplants without immunosuppression: Experimental approaches and possibilities for tolerance induction in clinical transplantation (1999) (12)
B Cells and Antibodies in Transplantation (2016) (12)
Cell mediated rejection. (2013) (12)
Induction of tolerance to alloantigen. (1999) (12)
HLA and organ transplantation. (1987) (12)
Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo (2019) (11)
The effect of purified class II major histocompatibility complex antigen on the survival of vascularized organ allografts in the rat. (1993) (11)
Increased expression of transforming growth factor-&bgr; and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts (2003) (11)
Novel biomarkers and functional assays to monitor cell-therapy-induced tolerance in organ transplantation (2015) (11)
Regulatory T cells--a journey from rodents to the clinic. (2007) (11)
Tolerance in renal transplantation: is mixed chimerism the missing link? (2009) (11)
Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways (2013) (11)
Comparison of the effect of protein micelles containing purified class I MHC antigen and a cytosolic preparation containing water soluble class I molecules on rat renal allograft survival. (1989) (11)
Autoimmunity and transplantation: a meeting at the crossroads in Berlin (2008) (11)
Is B Cell Tolerance Essential for Transplantation Tolerance? (2005) (11)
Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients. (1989) (11)
Haematopoietic stem cells transduced with a single donor class I major histocompatibility complex gene can induce operational tolerance to fully allogeneic cardiac allografts. (1999) (10)
Translating transplantation tolerance in the clinic: where are we, where do we go? (2009) (10)
Alternative approaches for the induction of transplantation tolerance. (1991) (10)
The induction of operational tolerance is not prevented by simultaneous administration of cyclosporin A1 (1997) (10)
Induction of donor major histocompatibility complex antigens may not always correlate with graft rejections. (1988) (10)
Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo. (2003) (10)
Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders (2017) (9)
Evidence that non-deletional mechanisms are responsible for inducing and maintaining unresponsiveness after intrathymic injection of non-professional antigen presenting cells. (2000) (9)
Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibody. (1996) (9)
Mechanism of induction of transplantation tolerance using donor antigen and anti-CD4 monoclonal antibody. (1991) (9)
Antigen‐Induced Tolerance to Organ Allografts a (1991) (9)
The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody. (1990) (9)
Cytotoxic cells may not be responsible for renal allograft rejection. (1988) (8)
Transplantation Research: Will We Ever Reach the Holy Grail? (2009) (8)
Increased Transplant Arteriosclerosis in the Absence of CCR7 is Associated With Reduced Expression of Foxp3 (2008) (8)
Anergy in allogeneic transplantation. (1993) (8)
Gene therapy in transplantation. (2001) (8)
ORAL ANTIGEN INDUCES ALLOGRAFT SURVIVAL BY LINKED SUPPRESSION VIA THE INDIRECT PATHWAY.: Abstract# 499 Poster Board #‐Session: P139‐II (2000) (8)
New insights on the mechanisms of acquired intrathymic tolerance (1999) (8)
Modulation of the CD4 molecule is a major event in the induction of transplantation tolerance with anti-CD4 monoclonal antibodies. (1997) (8)
Rat brain xenografts reverse hypogonadism in mice immunosuppressed with anti-CD4 monoclonal antibody (2004) (8)
Effect of anti-CD4 monoclonal antibody dosage when combined with donor antigen for the induction of transplantation tolerance. (1991) (8)
Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection. (1987) (8)
European research on cell and organ transplantation: towards novel opportunities? (2007) (8)
Oral antigen induces allograft survival by linked suppression via the indirect pathway. (2000) (8)
Increased tumour growth after blood transfusion. (1989) (8)
In vivo models of inflammation: immune rejection and skin transplantation in vivo. (2003) (8)
Immunogenetics of Heart Transplantation in Rodents (1997) (8)
Expression of HLA in isolated human pancreatic islets and cryopreservation. (1987) (7)
Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen. (2002) (7)
Quantification of CD4+ T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time‐Lapse Microscopy and Immune Synapse Detection (2016) (7)
Transplantation tolerance by donor MHC gene transfer. (2004) (7)
Results of Heart Transplantation in Mice (1998) (7)
SUPPRESSION MEDIATED BY ANERGIC CD4+ T CELLS REQUIRES STIMULATION BY MHC-PEPTIDE COMPLEXES AND CAN BE INDUCED IN THE PRESENCE OF COSTIMULATION1 (2001) (6)
Mouse endothelial CD40 expression does not play a role during the development of transplant arteriosclerosis. (2003) (6)
Donor Resting B Cells Induce Indefinite Prolongation of Fully Allogeneic Cardiac Grafts When Delivered with Anti-IgD Monoclonal Antibody (1998) (6)
Immunological principles of acute rejection (2011) (6)
Outlook for longer-lasting islets (2008) (5)
Oral administration of alloantigen induces indefinite prolongation of MHC mismatched cardiac allografts. (1999) (5)
Potential of gene transfer in transplantation. (1999) (5)
Intrathymic delivery of plasmid-encoding endoplasmic reticulum signal-sequence-deleted MHC class I alloantigen can induce long-term allograft survival (2004) (5)
The effect of pretreatment with a single cloned donor class I gene product on cardiac allograft survival in mice. (1987) (5)
Enhancing human regulatory T cells in vitro for cell therapy applications. (2017) (5)
DONOR-RECIPIENT MICROCHIMERISM AND TOLERANCE INDUCTION (REPLY) (1996) (5)
Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression. (1995) (5)
Impacts on Donor-Recipient HLA Matching on Operational Tolerance Following Pediatric Living-Donor Liver Transplantation (2011) (4)
INDUCTION OF OPERATIONAL TOLERANCE BY RANDOM BLOOD TRANSFUSION COMBINED WITH ANTI‐CD4 ANTIBODY THERAPY (1994) (4)
Genomic analysis identifies class II mismatches in serologically DR-compatible human renal allografts. (1988) (4)
CD40‐CD40L INDEPENDENT ACTIVATION OF CD8+ T CELLS CAN TRIGGER ALLOGRAFT REJECTION.: Abstract# 1152 (2000) (4)
An interactive computer program for the analysis of HLA class II restriction fragment patterns. (1988) (4)
B7-2+ low density APCS are as effective as B7-2- small resting B cells in inducing specific unresponsiveness to minor histocompatibility (miH) antigen(s) in vivo. (1997) (4)
Differential immunodominance of individual MHC locus products: implications for the induction of immunologic tolerance to allografts. (1997) (4)
Neonatal induction of tolerance to cardiac allografts. (1994) (4)
Defining the structural basis for human leukocyte antigen reactivity in clinical transplantation (2020) (4)
Concepts and Challenges in Organ Transplantation (2012) (4)
Neonatally induced transplantation tolerance to primarily vascularised cardiac allografts is not donor-specific. (1995) (4)
Syngeneic bone marrow transduced with a recombinant retroviral vector to express endoplasmic reticulum signal-sequence-deleted major histocompatibility complex class-I alloantigen can induce specific immunologic unresponsiveness in vivo (2003) (4)
Abstract 5467: Magnetic Resonance Imaging Of Renal Ischemia Reperfusion Injury Using Microparticles Of Iron Oxide Targeting VCAM-1 (2008) (4)
The ONE Study: Evaluation of Regulatory Cell Therapy in Kidney Transplantation Using a Harmonized Trial Design (2020) (4)
WHICH DONOR CELLS FACILITATE THE INDUCTION OF SPECIFIC IMMUNOLOGICAL UNRESPONSIVENESS TO ALLOANTIGENS IN VIVO? (2002) (4)
Advances in transplantation immunology. (1991) (4)
Induction of immunological unresponsiveness using recipient cells transfected with donor class I or class II MHC genes. (1989) (4)
Presence of regulatory T cells within tolerant graft of human liver and intestinal transplantation (2006) (4)
DQ Wa gives rise to a DQ beta restriction fragment pattern indistinguishable from that of the DQw3.2 sub-type of DQw3. (1988) (4)
Cytokines as mediators in immunologic tolerance (2001) (3)
Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype. (1987) (3)
This information is current as Conditional but Limited Role for IL-4 Induction of Transplantation Tolerance : A Evidence for Immune Regulation in the (1999) (3)
The relevance of adhesion molecules in the classification of squamous cell carcinoma of the head and neck. (2005) (3)
Splenectomy and renal allograft survival in the rat (1988) (3)
Regulatory T cells--an emerging role in transplantation. (2004) (3)
Bridging innate with adaptive immunity in transplantation: triggers, sensors, and modulators. (2014) (3)
Taking stock and moving forward (2003) (3)
Immunobiology of solid organ transplantation. (1999) (3)
The role of individual minor histocompatibility antigens in cardiac allograft rejection. (1989) (3)
PECAM-1 (CD31) expression on donor endothelial cells attenuates transplant arteriosclerosis in aortic allografts (2002) (3)
Syngeneic bone marrow cells expressing a single donor class I MHC molecule are more effective at inducing tolerance than donor bone marrow cells. (1997) (3)
THE COMBINED EFFECT OF PERIOPERATIVE DONOR SPLEEN CELLS OR KC1‐EXTRACTED ANTIGEN AND CYCLOSPORINE ON RENAL ALLOGRAFT SURVIVAL IN THE RAT (1991) (3)
Immunogenic (MHC class II+) cells are able to induce unresponsiveness when delivered with anti-CD4 monoclonal antibody. (1998) (3)
The needs for a Global Alliance for Transplantation. (2005) (3)
Transplantation More questions than answers (1998) (3)
In vivo cytokine production by allospecific CD8+ transgenic T cells after heart transplantation. (1999) (2)
Isolation of Human Regulatory T Lymphocytes by Fluorescence-Activated Cell Sorting. (2019) (2)
Restriction fragment analysis of the HLA Class II region: Application to tissue transplantation (1989) (2)
Hybridization analysis reveals novel DQw3 alpha-beta associations suggesting a recombination point between DQ alpha and DQ beta on the HLA-DR4 haplotype. (1988) (2)
Prolongation of cardiac allograft survival in the mouse using cloned donor class I antigens (1985) (2)
Small, resting B cells induce prolonged survival of cardiac allografts mismatched for single minor, but not multiple minor, single major, or multiple major and minor histocompatibility antigens. (1997) (2)
Class I antigen pretreatment prolongs allograft survival in mice by induction of suppressor cells. (1987) (2)
Cytotoxic cells alone are not sufficient to mediate renal graft rejection. (1989) (2)
Dendritic cells in the blood transfusion effect. (1987) (2)
CD45RA distinguishes CD4+CD25+CD127-/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus mediated inhibition of suppression. (2016) (2)
The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation. (2016) (2)
Regulatory T Cells: Professional Suppressor Cells (2004) (2)
Restriction enzyme analysis of HLA class II antigens in renal transplantation. (1987) (2)
Immunoregulation in Transplantation (2016) (2)
B Cell Repopulation after Alemtuzumab Treatment in Kidney Transplant Recipients - Transient Increase in Transitional B Cells and Long Term Dominance of Naïve B Cells: 706 (2012) (2)
Ly-6Chi monocytes: a potential target for preventing transplant arteriosclerosis? (2013) (2)
Avenues for acquired immune tolerance. (1990) (2)
Alemtuzumab Treatment Leads to Delayed Recovery of T Follicular Regulatory Cells, and May Therefore Predispose Patients to de novo Donor-Specific Antibody Formation (2019) (2)
Biomarkers of tolerance in kidney transplants (2007) (2)
Comparison of the effects of exposure to a single or multiple donor alloantigens in the development of transplant arteriosclerosis. (2001) (2)
Donor-specific unresponsiveness to cardiac allografts in the mouse: an examination of mechanisms. (1991) (2)
Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts. (1988) (2)
INDICES OF TOLERANCE: INTERIM REPORT. (2006) (2)
ANALYSIS OF PERIPHERAL BLOOD MONONUCLEAR CELLS IN OPERATIONAL TOLERANCE AFTER PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION (LDLT) (2004) (2)
Investigation into the onset and progression of transplant arteriosclerosis in a mice aortic retransplantation model (2008) (2)
Evaluation and Optimisation of Non-Autologous Human Regulatory T Cell Therapy for Transplantation. (2014) (2)
EVIDENCE THAT TREATMENT WITH DHRS9+ REGULATORY MACROPHAGES INDUCED BY FCγRIII LIGATION AND IFN-γ STIMULATION PROMOTES RENAL ALLOGRAFT TOLERANCE IN PATIENTS: 3261 (2010) (2)
A comparison of 51chromium and Hoechst 33342 for monitoring lymphocyte migration in vivo. (1989) (2)
Modulation of CD27/CD70 Co-Stimulatory Pathway may Allow for the Generation of a More Potent Human Regulatory T Cell Product for Cell Therapy (2017) (2)
Antigen-induced suppression: The role of Class I major histocompatibility antigens (1985) (2)
Institutional Repository Single cell tracking of gadolinium labeled CD 4 ( + ) T cells by laser ablation inductively coupled plasma mass spectrometry (2017) (2)
Immunoregulatory T-cells can mediate specific unresponsiveness to alloantigens in vivo. (2001) (2)
The importance of sharing major histocompatibility complex and minor antigens between blood and graft donors in the blood transfusion effect. (1987) (2)
Single cell tracking of gadolinium labelled CD 4 + T cells by laser ablation inductively coupled plasma mass spectrometry ( LA-ICP-MS ) (2014) (2)
How to Escape the Immune Response: What Tumors Teach to Transplant Physicians/Immunologists. (2017) (1)
Faculty Opinions recommendation of Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans. (2015) (1)
IN-VIVO MAGNETIC RESONANCE IMAGING OF RENAL ISCHAEMIA/REPERFUSION INJURY USING MICROPARTICLES OF IRON OXIDE TARGETING VASCULAR CELL ADHESION MOLECULE 1 (2009) (1)
Potential of gene transfer for the induction of specific unresponsiveness to alloantigens in vivo. (1999) (1)
PROPE TOLERANCE: A MORE REALISTIC APPROACH TO IMPROVE LONG-TERM OUTCOMES FOR PEDIATRIC LIVING-DONOR LIVER TRANSPLANTATION: 2284 (2010) (1)
REGULATORY T CELL THERAPY PROLONGS HUMAN SKIN ALLOGRAFT SURVIVAL IN A HUMANISED MOUSE MODEL: 684 (2010) (1)
The persistence of transplant arteriosclerosis despite CD154 blockade. (2001) (1)
The relevance of experimental studies to clinical practice in renal transplantation. (1986) (1)
HUMAN REGULATORY T CELLS PREVENT ISLET ALLOGRAFT REJECTION (2008) (1)
Transplantation tolerance--discussion. (2001) (1)
Mediate Tolerance to Alloantigens In Vivo IL-10 Is Required for Regulatory T Cells to (2001) (1)
DIRECT FUNCTIONAL ACTIVATION OF CD4+CD25+FOXP3+ T CELLS BY INTRAVENOUS IMMUNOGLOBULINS PROMOTES SKIN ALLOGRAFT ACCEPTANCE: 21 (2008) (1)
Intrathymic inoculation of donor B cells prolongs cardiac allograft survival by non-deletional mechanisms. (1999) (1)
Editorial: Transplant Rejection and Tolerance—Advancing the Field through Integration of Computational and Experimental Investigation (2017) (1)
Anti-CD28 Antagonism Using a Monovalent Fab Antibody for the Prolongation of Human Skin Allograft Survival. (2014) (1)
F.96. T Cell Repertoire Analysis of Stable Kidney Graft Recipients for Detection of Low and High Risk of Chronic Rejection (2008) (1)
Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice. (1993) (1)
Raw data for Figure 5: The presence of IDO and PGE-2 inhibitors reduce the suppression of T cell proliferation by Mesoangioblasts/HIDEMs (2013) (1)
Immunological pathways of rejection in sensitized recipients (1997) (1)
High Numbers of FOXP3(+) T Cells and Poor Lymphocyte Proliferation Identifies Patients at High Risk of Developing Squamous Cell Cancer after Renal Transplantation. (2009) (1)
Gene Transfer and Tolerance Induction (1998) (1)
In vivo differentiation of alloreactive CD8+ T cells after murine cardiac allograft transplantation. (1999) (1)
Transplantation biology: recent advances. 5th basic sciences symposium of the Transplantation Society. Chautauqua, NY, USA, 6-11 September 1997. (1998) (1)
Regulation of the Alloimmune Response (2012) (1)
Principles of transplantation immunology (2010) (1)
Long-term restoration of gonadal activity with xenografts of preoptic area tissue in hypogonadal (hpg) mice. (1998) (1)
Approaches to the Induction of Tolerance (2008) (1)
Recruitment of FOXP3 expressing regulatory T cells into tolerant graft of human liver transplantation (2008) (1)
Subdivision of Haplotype HLA-DR3 by Biochemical and Functional Analysis (1989) (1)
Neutralizing Interleukin-4 Prevents Transplant Arteriosclerosis Mediated by Indirect Pathway T Cells Under CD40-CD154 Costimulation Blockade (2008) (1)
The Transplantation Society: Building on Success (2006) (1)
Hybridization analysis reveals novel DQw3 α-β associations suggesting a recombination point between DQα and DQβ on the HLA-DR4 haplotype (2004) (1)
Peripheral tolerance to alloantigen in the adult. (1993) (1)
Analysis of peripheral blood mononuclear cells in operational tolerance after living F-donor liver transplantation (LDLT). (2004) (1)
In vivo generated CD25(+)CD4(+) T cells regulate islet allograft rejection by preventing effector cell migration into the graft (2005) (1)
Mechanisms of unresponsiveness to alloantigens in vivo. (1998) (1)
The visualization of T cell responses. (1999) (1)
Co-Stimulatory Modulation of Human Regulatory T cells for Enhanced Immunotherapy (2018) (1)
The UK ONE Study trial: safety and feasibility of regulatory T (Treg) cell therapy in renal transplantation (2016) (1)
Tissue targeted regulatory T cell therapy prevents human skin allograft rejection in a humanised mouse model (2013) (1)
CD8+ T CELL SENESCENCE IS A DISTINCT IMMUNOLOGICAL STATE THAT IDENTIFIES LONG-TERM RENAL TRANSPLANT RECIPIENTS AT INCREASED RISK OF FUTURE MALIGNANCY (2020) (1)
Upregulation of FOXP3 Expression of Donor Specific CD4(+)CD25(++)IL-7(low+) Regulatory T Cells in Operationally Tolerant Recipients after Pediatric Living-Donor Liver Transplantation (2011) (1)
Graft Rejection: Immunological Suppression (2003) (0)
DOMINANT T CELL REGULATION ACHIEVED EX-VIVO VIA IFN-GAMMA/STAT-1 SIGNALING AND NITRIC OXIDE INDUCTION: 19 (2008) (0)
False “tolerance” induction following islet transplantation in the mouse (1996) (0)
PRETREATMENT WITH ANTI-CD4 PLUS ALLOANTIGEN RESULTS IN THE INDUCTION OF A DISTINCT PATTERN OF CHEMOKINE EXPRESSION FOLLOWING CARDIAC ALLOGRAFT TRANSPLANTATION. (2004) (0)
Transplant Recipients Macrophages Administered to Renal and Trafficking of Human Regulatory Cutting Edge: Immunological Consequences (2011) (0)
The Novel IL-1 Family Member IL-33 Promotes Immature DC, Facilitates Th2 Responses, and Markedly Prolongs Cardiac Allograft Survival. (2010) (0)
Selective blockade of CD28 costimulation prevented human alloskin graft rejection in a humanised mouse model (2016) (0)
The induction of immunologic unresponsiveness by antigen pretreatment is mediated by a CD4 T cell that appears transiently in the spleen and subsequently in the TDL. (1989) (0)
Dampened inflammatory signalling and myeloid-derived suppressor- (2022) (0)
The Role of CD4+CD25+ Regulatory Cells in a Mouse Transplantation Tolerance Model: CTLA-4 and IL-10-Dependent Regulation of Skin Allograft Rejection (2002) (0)
PLASMA CHOLESTEROL ACCELERATES TRANSPLANT ARTERIOSCLEROSIS AND CHRONIC REJECTION THROUGH INCREASED RECRUITMENT OF INFLAMMATORY MONOCYTES INTO THE ARTERIAL WALL: 1903 (2010) (0)
Formulation of guidelines for aseptic techniques to reduce cell culture contamination by Carrel (2011) (0)
THE ROLE OF CD40 IN VASCULAR REJECTION - EVIDENCE AGAINST THE INVOLVEMENT OF ALLOANTIBODY (1999) (0)
University of Groningen A Shift towards Pro-Inflammatory CD16+Monocyte Subsets with Preserved Cytokine Production Potential after Kidney Transplantation Vereyken, (2013) (0)
Special article Operational tolerance after liver transplantation q (2009) (0)
Dominant iNKT cells subsets differentially control immunity to allografts according to the site of T cell priming (2016) (0)
Graft endothelial repopulation by recipient cells in the absence of an adaptive immune response is IFN-gamma-dependent and may protect from alloinjury (2006) (0)
Direct allorecognition: a mechanism in intrathymic tolerance induction. (1999) (0)
CD1d/NKT cells (PP-006) (2010) (0)
238. Stem Cell Gene Delivery to Immunocompetent Mice Using a Non-Myeloablative Regimen Results in Long-Term Transgene Expression and Stable Mixed Chimerism (2005) (0)
QUALITATIVE AND TEMPORAL DIFFERENCES BETWEEN RENAL, CARDIAC AND SKIN ALLOGRAFT REJECTION IN MICE (2004) (0)
CONCURRENT SESSION 83: IMMUNE PROFILING AND MOLECULAR DIAGNOSIS (2006) (0)
CD8+ T CELLS ACTIVATED AFTER ALLO-SKIN TRANSPLANTATION ACQUIRE RESISTANCE TO ANTIBODY MEDIATED DEPLETION (2006) (0)
CD4+ T CELLS CONDITIONED IN VITRO WITH IFN-γ AND ALLO- APC ABROGATE TRANSPLANT ARTERIOSCLEROSIS CAUSED BY CD25-CD4+ EFFECTORS – ROLE OF RESTIMULATION WITH ALLOANTIGEN (2006) (0)
Laudatio to Professor Leslie Baruch Brent on the occasion of his honorary ESOT membership (2012) (0)
CD25+GITR+ REGULATORY T CELLS PLAY AN ESSENTIAL ROLE IN ALLOGRAFT PROTECTION IN NON-LYMPHOPENIC TOLERISED PRIMARY TRANSPLANT RECIPIENTS: 296 (2008) (0)
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry (2017) (0)
Alloantigen-Specific Immunoregulatory Cells + CD 25 + Cutting Edge : CD 4 (2002) (0)
A Novel Mechanism of Human Regulatory T cell Function in Proinflammatory Conditions (2018) (0)
CD45RA identifies TSDR demethylated regulatory T cells with a stable phenotype and suppressive cytokine profile (2016) (0)
Functional dichotomy of NK cells in organ transplantation (2007) (0)
Faculty Opinions recommendation of Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. (2016) (0)
PRODUCTION, CHARACTERIZATION AND IMPLANTATION OF ACELLULAR PORCINE RENAL SCAFFOLDS IN PIGS: 902 (2010) (0)
Measurement of a 5-gene panel in whole blood in kidney transplant recipients with acute rejection and stable controls (2015) (0)
CD4+ memory t cells (Tm) do not provide "help" to CD4+ naive t cells (Tn) to overcome the effects of immunosuppression (2013) (0)
Cytotoxic activity in transfused and untreated rats following renal transplantation (1987) (0)
De-Methylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Kidney Transplant Recipients.: Abstract# B1169 (2014) (0)
Natural Killer T (NKT) Cell Activation Attenuates Allograft Rejection Through The Induction of Myeloid-Derived Suppressor Cells (MDSC).: Abstract# 2950 (2014) (0)
PROMOTION OF IMMUNOREGULATION BY SELECTIVE BLOCKADE OF HUMAN CD28 COSTIMULATORY SIGNALING (2015) (0)
Response to "reconstruction of the hepatic artery in liver transplantation in mice: Mandatory or useless?" (2004) (0)
Transplantation: A Report of Progress (2006) (0)
CROSS-PLATFORM BIOMARKER SIGNATURE TO IDENTIFY RENAL TRANSPLANT TOLERANCE IN HUMANS.: 3352 (2010) (0)
CORRELATION OF EARLY TOLERANCE MARKER EXPRESSION WITH LONG TERM GRAFT FUNCTION AND SURVIVAL (2004) (0)
The potential role of CD25+CD4+ regulatory T cells in the induction and maintenance of transplantation tolerance in humans (2005) (0)
Transplantation: A Report of Progress (2005) (0)
USE OF ANTI-CD4 MONOCLONAL ANTIBODIES FOR TOLERANCE INDUCTION (1994) (0)
Addressing the Challenge of Autoimmunity in the Treatment of Diabetes with Stem Cells (2013) (0)
HUMAN REGULATORY T CELL THERAPY IN THE PREVENTION OF TRANSPLANT ARTERIOSCLEROSIS: 888 (2008) (0)
Regulatory T Cells: Professional (2004) (0)
Raw data for Figure 4A: Neutralising antibodies against IFN-γ and TNF-α reduce the immunosuppressive capacity of Mesoangioblasts/HIDEMs (2013) (0)
Immunology and tolerance of the composite tissue allograft (2006) (0)
FUNCTIONAL ANALYSES OF THE PERIPHERAL BLOOD MONONUCLEAR CELLS IN LIVING RELATED LONG TERM RENAL TRANSPLANT RECIPIENTS (2005) (0)
Measurement of Tregs – Back To Basics (2019) (0)
GITR ACTIVATION IN DONOR SPECIFIC TRANSFUSION ACCELERATES ALLOGRAFT REJECTION (2004) (0)
Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01 (2019) (0)
Cell Tracking By Gadolinium Labelling and Mass Spectrometry:-A Tool for Evaluating The Persistence of Cellular Therapies in Transplantation (2014) (0)
EX VIVO GENERATED TREG AMELIORATE TRANSPLANT ARTERIOSCLEROSIS BY INHIBITING EFFECTOR CELL PRIMING AND GRAFT INFILTRATION: 1445 (2008) (0)
PLASMA LIPIDS INFILTRATE ARTERIAL ALLOGRAFTS AND ACCELERATE THE DEVELOPMENT OF TRANSPLANT ARTERIOSCLEROSIS: 311 (2008) (0)
ANTIBODIES TO ALLOGENEIC AND AUTOLOGOUS ENDOTHELIAL PRECURSOR CELLS DETECTED BY XM-ONE ASSAY: ANALYSIS IN LIVING DONOR RENAL TRANSPLANTS: 2169 (2010) (0)
The South Carolina Investigators in Transplantation (SCIT) presents (2015) (0)
Role of OX40-OX40L interactions in the immune response to solid organ allografts (2013) (0)
Evidence for an accelerated rejection response to cardiac allografts in antigen-treated mice which then resolves. (1987) (0)
BYSTANDER REGULATORY T CELLS PLUS SUB- OPTIMAL IMMUNOTHERAPY CONTROLS ALLOGRAFT REJECTION: 1447 (2008) (0)
Th17 cells in organ transplantation (2009) (0)
BOOK REVIEW LIVING DONOR KIDNEY TRANSPLANTATION (2005) (0)
Peripheral tolerance: the transplantation model (2004) (0)
LDVA (2019) (0)
Pretransplant blood transfusion with additional immunotherapy tolerizes recipients to islet allografts (2005) (0)
An investigation of "tolerance" induction following islet allotransplantation in the mouse. (1997) (0)
Indirect presentation of alloantigen resulted in suppression of the activity of alloantigen specific cytotoxic T cells and B cells after oral delivery of alloantigen and non-depleting CD4 mAb (1999) (0)
Feasibility and Long Term Safety of T Regulatory Cell Therapy in Kidney Transplantation (2020) (0)
Transplantation tolerance. (1991) (0)
Blockade of OX40-OX40L Interactions Attenuates Allograft Rejection Mediated by CD4 T Cells That Recognize Alloantigen through the Direct but Not Indirect Pathway of Allorecognition (2012) (0)
Living Donor Kidney Transplantation (2005) (0)
Myeloid-Derived Suppressor Cells (MDSCs) Induced In Vivo Following Activation of Invariant Natural Killer T (iNKT) Cells Prolong the Survival of Skin Allografts: 2276 (2012) (0)
Tolerance induction in cardiac transplantation (1999) (0)
Allograft Survival Cell-Dependent Promotion of Cardiac Cells , and Mediates Regulatory T + Foxp 3 + and Regulatory T Cells , including ST 2 L int Gr-1 + IL-33 Expands Suppressive CD 11 b (2011) (0)
Approaches to immunological tolerance and potential application in pancreatic islet transplantation (2010) (0)
Identification of tolerant patients based on a combinational analysis of foxp3 and aMannosidase transcription (2007) (0)
CD4‐specific monoclonal antibody can prolong cardiac allograft survival without T‐cell depletion (1992) (0)
Blood transfusion induces specific cytotoxic cells. (1987) (0)
CD4+CD25+ Regulatory T Cells in a Transplantation Model: Ability to Prevent Allograft Rejection and Mediate Bystander Regulation (2003) (0)
Mechanisms of Immune Regulation (2014) (0)
IL-1RII expressed by human regulatory T cells: a decoy strategy to ensure regulation (2012) (0)
Chapter 23 – Approaches to the Induction of Tolerance (2008) (0)
Transplantation: a report of progress. (2008) (0)
Rag2(-/-)/gc(-/-) mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution: A marked improvement over the SCIDhu model (2006) (0)
BLOCKADE OF OX40 COSTIMULATION REDUCES THE ALLOREACTIVE EFFECTOR T CELL POOL AND PREVENTS CD8+ T CELL MEDIATED SKIN ALLOGRAFT REJECTION.: 2142 (2010) (0)
Regulatory T cells in transplantation - from preclinical models to clinical study (2011) (0)
INDIRECT ALLORECOGNITION PLAYS A PIVOTAL ROLE IN THE PATHOGENESIS OF TRANSPLANT ARTERIOSCLEROSIS.: Abstract# 905 Poster Board #‐Session: P162‐III (2000) (0)
Monitoring peripheral blood regulatory T cells on clinically defined groups of kidney transplant recipients (2007) (0)
CD25+CD4+ REGULATORY T CELLS GENERATED IN VIVO PREVENT ISLET ALLOGRAFT REJECTION BY BLOCKING THE RECRUITMENT OF EFFECTOR CELLS INTO THE GRAFT (2004) (0)
Long-term allograft survival following intrathymic application of plasmid encoding endoplasmic reticulum signal sequence deleted MHC class I alloantigen (2003) (0)
PeripheralToleranceto AlloantigenResultsfrom AlteredRegulationof the Interleukin2 Pathway (1991) (0)
Evidence for immunoregulation by Cd4 T cells in the induction of specific immunological unresponsiveness to alloantigens in vivo (1997) (0)
INTRAVENOUS IMMUNOGLOBULINS INDUCE DIRECT FUNCTIONAL ACTIVATION OF CD4+CD25+FOXP3+T CELLS: A VALUABLE TOOL AFTER TRANSPLANTATION. (2008) (0)
TWO DISCRETE WAVES OF T CELL ACTIVATION FOLLOWING TRANSPLANTATION OF A SKIN ALLOGRAFT. (2004) (0)
RECRUITMENT OF FOXP3 EXPRESSING T CELLS INTO THE GRAFTS OF TOLERANT HUMAN LIVER TRANSPLANT RECIPIENTS: 211 (2008) (0)
THE EFFECT OF CONVERSION TO SIROLIMUS ON IMMUNE PHENOTYPE IN TRANSPLANT RECIPIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA: 289 (2008) (0)
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells (2020) (0)
Class I major histocompatibility antigen pretreatment prolongs cardiac allograft survival in mice (1985) (0)
CD8+ MEMORY T CELLS ELICIT ACCELERATED REJECTION THROUGH RAPID RECRUITMENT OF GR-1+ NEUTROPHILS TO THE ALLOGRAFT: 742 (2008) (0)
WELCOME TO A NEW TRANSPLANTATION JOURNAL (2000) (0)
Faculty Opinions recommendation of Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a. (2016) (0)
NECESSITY FOR MAINTENACE THERAPY AFTER CAMPATH-1H INDUCTION. (2006) (0)
Islet Allografts to T Cell-Mediated Rejection Differential Susceptibility of Heart, Skin, and (2013) (0)
THE ROLE OF CD4+CD25+ REGULATORY T CELLS IN OPERATIONAL TOLERANCE AFTER LIVING DONOR LIVER TRANSPLANTATION (2004) (0)
The induction of operational tolerance is not prevented by simultaneous administration of cyclosporin A 1 (1997) (0)
SUPPRESSION OF SKIN GRAFT REJECTION MEDIATED BY ALLOANTIGEN-REACTIVE CD25+CD4+ REGULATORY T CELLS DELAYS BUT DOES NOT COMPLETELY PREVENT T CELL PRIMING (2004) (0)
Induction of Specific Immunosuppression in the Mouse Using Cells of Recipient Origin Transfected with Genes from the Organ Donor (1989) (0)
Intrathymic Administration of B Cells Induces Prolonged Survival of Fully Allogeneic Cardiac Grafts by Non-deletional Mechanisms (1998) (0)
Homing of Therapeutic Human Regulatory T Cells to the Allograft Site Enhances Transplant Survival: 679 (2012) (0)
DEPLETION OF CD25+ T CELLS OR LIGATION OF GITR REVERSES THE INDUCTION OF OPERATIONAL TRANSPLANTATION TOLERANCE (2004) (0)
Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants (2009) (0)
Abstract Session IV - Transplantation (2003) (0)
The impact of CD28 blockade by anti-CD28 antibody on the intimal proliferation in a murine aorta transplantation model. (2005) (0)
Ex Vivo Assessment of Transplantation Tolerance Using Time Lapse Microscopy (2014) (0)
Alloantigen-induced speci c immunological unresponsiveness (2003) (0)
In vivo Visualisation of Cytotoxic T Cell Activation and Differentiation during Allograft Rejection (1999) (0)
336.1: Spatial Transcriptomic Profiling Reveals Immunosuppression And Immunosenescence-Driven Skewing of Immune Response in Cutaneous Squamous Cell Carcinoma Immune Response in Kidney Transplant Recipients, Associating With Adverse Cancer-Related Outcomes (2022) (0)
Activation of the immune system: A corollary of transplantation with ES cell-derived tissues (2008) (0)
A brief in vitro activation is sufficient to equip naturally-occurring regulatory T Cells to control allograft rejection long-term (2014) (0)
Uncovering the Role of Immune Regulatory B Cells in a Mouse Model of Transplant Tolerance.: Abstract# D2674 (2014) (0)
4 Mechanisms of rejection (1994) (0)
Faculty Opinions recommendation of Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. (2016) (0)
ALLOANTIGEN-REACTIVE CD25+CD4+ REGULATORY T CELLS GENERATED IN VIVO INHIBIT TRANSPLANT ARTERIOSCLEROSIS (2006) (0)
Pre-transplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy (2011) (0)
HLA in Transplantation (1986) (0)
HLA Class II Antigens — Significance in Organ Transplantation (1989) (0)
Functional inhibition of IL-4 is required to prevent the development of transplant arteriosclerosis in MHC-Class I mismatched aortic allografts following CD40-CD154 costimulation blockade (2002) (0)
336: Ischemic time, minor and major antigen mismatches all contribute independently to endothelial cell repopulation after aorta transplantation in mice (2006) (0)
Alloantigen-Driven Regulatory T Cells Are More Effective at Regulating Rejection in Immunocompetent Recipients than Freshly Isolated or Expanded nTreg: 1339 (2012) (0)
Immune Monitoring in Transplantation – Biomarkers for Personalised Immunosuppression (2019) (0)
Kathryn Wood, DPhil, FMedSci: Professor of Immunology, University of Oxford and Editor of Transplantation, 1991-2014. (2015) (0)
RAPID RECRUITMENT OF FOXP3+ REGULATORY T CELLS INTO CARDIAC ALLOGRAFTS FOLLOWING THE INDUCTION OF SPECIFIC UNRESPONSIVENESS TO ALLOANTIGEN IN VIVO: 735 (2008) (0)
Animal Models of Transplantation (2016) (0)
Title Minimum Information about T Regulatory Cells : A Step toward Reproducibility and Standardization Permalink (2018) (0)
Transplant Immunobiology – Mechanisims of Graft Rejection (2001) (0)
LOCAL ADMINISTRATION OF IN VIVO GENERATED TREG PREVENT THE REJECTION OF ISLET (2006) (0)
EVIDENCE THAT THE GRAFT PLAYS AN IMPORTANT ROLE IN MAINTAINING TOLERANCE TO DONOR ALLOANTIGENS: 1463 (2008) (0)
Stem Cell-Based Approach to Immunomodulation (2014) (0)
Chronic Vascular Rejection Despite CD154 Blockade is Mediated by CD8+ T Cells (1999) (0)
An analysis of the adaptive immune response towards an embryonic stem cell grafts (2007) (0)
Mechanisms of Rejection and Tolerance In Transplantation (2019) (0)
Ex vivo expanded human treg inhibit the development of transplant arteriosclerosis in a humanized in vivo model (2008) (0)
T Cell Therapy In Transplantation (2019) (0)
Investigation of a novel multi-lineage human-mouse chimeric model for in vivo transplantation research (2016) (0)
Intrathymic delivery of plasmid‐encoding endoplasmic reticulum signal‐sequence‐deleted MHC class I alloantigen can induce long‐term allograft survival (2004) (0)
Introduction of the President of The transplantation society, Nicholas Tilney. (2008) (0)
Phosphodiesterase 3b Inhibition Expands Stable Regulatory T Cells for Cell Therapy in Transplantation (2015) (0)
Suppression of renal allograft rejection in the rat using purified plasma membrane and endoplasmic reticulum preparation expressing donor class I major histocompatibility complex antigen. (1987) (0)
Mechanisms of rejection. (1994) (0)
ANALYSIS OF THE POTENTIAL ROLE OF CD25hi CD4+ REGULATORY T CELLS IN HUMAN LONG TERM SURVIVING LIVING RELATED KIDNEY TRANSPLANT RECIPIENTS (2004) (0)
Regulatory T Cells to Alloantigen T Cells and + of Effector/Memory CD4 A Diametric Role for OX40 in the Response (2013) (0)
Conversion to Sirolimus in Kidney Transplant Recipients with Squamous Cell Cancer Permits Potential Protective Changes in Immune Phenotype (2012) (0)
Prolongation of renal allograft survival by adoptive transfer of TDL from blood transfused hosts. (1987) (0)
EOSINOPHILS ARE MAJOR EFFECTOR CELLS FOR THE DEVELOPMENT OF TRANSPLANT ARTERIOSCLEROSIS AND DEPEND ON THE PRESENCE OF IL‐4.: Abstract# 722 (2000) (0)
Faculty Opinions recommendation of Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. (2013) (0)
Post-transcriptional enhancement of FOXP3 protein plays a key role in tolerance after human liver transplantation (2007) (0)
This information is current as T Cell Help + Independently of CD 4 Generated in Response to Alloantigen T Cells Can Be + Effector and Memory CD 8 (2006) (0)
GRAFT-PROTECTIVE REGULATORY T CELLS DEVELOP FROM FOXP3-NEGATIVE PRECURSORS IN VIVO: 734 (2008) (0)
Overexpression of haem oxygenase 1 protects allogeneic thyroid grafts from rejection in naive mice (2000) (0)
Natural killer cell regulatory receptor changes following tolerance induction. (2001) (0)
CD44 Blockade Generates Functional iTreg In Vitro By Reducing Memory T Cell IL-6 Production (2014) (0)
Islet allografts: rejection and tolerance induction. (1999) (0)
PRE-TRANSPLANT ASSESSMENT FOR LIVING DONOR RENAL TRANSPLANTATION: EVALUATION OF THE XM-ONE ASSAY (2009) (0)
ALLOGENEIC TREG GENERATED IN VITRO WITH RETINOIC ACID AND TGF-β CONTROL CYTOKINE PRODUCTION AND ALLOGRAFT REJECTION.: 621 (2010) (0)
Graft Rejection: Immunological (2010) (0)
Cell therapy (DC, Treg, NKT) (PP-040) (2010) (0)
in a Failure to Generate Memory T Cells Rejection by Regulatory T Cells Culminates Location and Time-Dependent Control of (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kathryn J. Wood?

Kathryn J. Wood is affiliated with the following schools:

Kathryn J. Wood's Academic­Influence.com Rankings

Kathryn J. Wood's Degrees

Why Is Kathryn J. Wood Influential?

Kathryn J. Wood's Published Works

Published Works

What Schools Are Affiliated With Kathryn J. Wood?

Kathryn J. Wood's AcademicInfluence.com Rankings